Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Cash & Equivalents (2016 - 2026)

Axogen has reported Cash & Equivalents over the past 17 years, most recently at $82.7 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 356.75% year-over-year to $82.7 million; the TTM value through Mar 2026 reached $82.7 million, up 356.75%, while the annual FY2025 figure was $35.5 million, 29.01% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $82.7 million at Axogen, up from $35.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $82.7 million in Q1 2026 and troughed at $7.7 million in Q1 2023.
  • A 5-year average of $24.1 million and a median of $19.2 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 77.73% in 2022 and later soared 356.75% in 2026.
  • Year by year, Cash & Equivalents stood at $15.3 million in 2022, then skyrocketed by 102.98% to $31.0 million in 2023, then dropped by 11.18% to $27.6 million in 2024, then grew by 29.01% to $35.5 million in 2025, then soared by 132.51% to $82.7 million in 2026.
  • Business Quant data shows Cash & Equivalents for AXGN at $82.7 million in Q1 2026, $35.5 million in Q4 2025, and $23.9 million in Q3 2025.